Tina Duong Cunningham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tina Duong Cunningham has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Sarah C. DeShields
The Center for Health Analytics and Discovery, Eastern Virginia Medical School, Harry Lester Building, 651 Colley Avenue, Norfolk, VA, 23507, USA
3 shared publications - Andrea Ries Thurman
Department of Obstetrics and Gynecology, CONRAD, Eastern Virginia Medical School, Norfolk, VA, United States
1 shared publication B. C. Martin
Graduate Program in Public Health, Norfolk, VA, USA
1 shared publicationB. S. Di Pace
Eastern Virginia Medical School
1 shared publication- Betsy C. Herold
Division of Pediatric Infectious Diseases at the Children’s Hospital at Montefiore and the Albert Einstein College Medicine
1 shared publication Brian S. Di Pace
Graduate Program in Public Health, Eastern Virginia Medical School, Norfolk, Virginia
1 shared publication
Latest Publications
- 25 April 2017
- Published by Springer Nature in Journal of Community Health
- Vol. 42 (6) , 1111-1117
Exploring Racial, Gender, and Insurance Disparities in Patients with Osteoporotic Fractures
The objective of this study is to examine racial, gender, and insurance disparities in hospital outcomes among patients diagnosed with osteoporotic fractures aged 55 years and older. A total of 36,153 patients were included in this study. The sample was constructed from de-identified patient-level data for 2011 through 2014 from the Virginia Health Information (VHI) inpatient discharge database. Differences in mortality and 30-day readmission across race, gender, and insurance status were examined using logistic regression and generalized linear models for hospital charges and length of stay. Whites and Asians had a shorter stay than Blacks [5.2 days (95% confidence interval (CI) 5.1–5.3) and 5.0 days (95% CI 4.7–5.2) vs. 5.6 days (95% CI 5.4–5.7)], while Hispanics had a significantly longer stay [6.0 days (95% CI 5.6–6.5)]. On average, total charges were the highest among Blacks [$37,916 (95% CI 36,784–39,083)]. All outcomes were poorer for men than women. Privately and publicly insured patients were more likely to be readmitted [odds ratio (OR) 1.6 (95% CI 1.0-2.6) and OR 2.0 (95% CI 1.3–3.2)] and had a shorter stay than the uninsured [4.9 days (95% CI 4.8–5.0) and 5.2 days (95% CI 5.1–5.3) vs. 5.7 days (95% CI 5.4–6.0)], while privately insured patients had considerably lower total charges than those who were uninsured [$34,163 (95% CI 33,214–35,139) vs. $36,335 (95% CI 34,334–38,452)]. As evidenced from this study, there are racial, gender, and insurance disparities in health outcomes. These results and further exploration of these disparities could provide information necessary for strategies to improve these outcomes in at-risk patients diagnosed with osteoporotic fractures.
- 25 April 2017
- Published by Springer Nature in Journal of Community Health
- Vol. 42 (6) , 1111-1117
Exploring Racial, Gender, and Insurance Disparities in Patients with Osteoporotic Fractures
The objective of this study is to examine racial, gender, and insurance disparities in hospital outcomes among patients diagnosed with osteoporotic fractures aged 55 years and older. A total of 36,153 patients were included in this study. The sample was constructed from de-identified patient-level data for 2011 through 2014 from the Virginia Health Information (VHI) inpatient discharge database. Differences in mortality and 30-day readmission across race, gender, and insurance status were examined using logistic regression and generalized linear models for hospital charges and length of stay. Whites and Asians had a shorter stay than Blacks [5.2 days (95% confidence interval (CI) 5.1–5.3) and 5.0 days (95% CI 4.7–5.2) vs. 5.6 days (95% CI 5.4–5.7)], while Hispanics had a significantly longer stay [6.0 days (95% CI 5.6–6.5)]. On average, total charges were the highest among Blacks [$37,916 (95% CI 36,784–39,083)]. All outcomes were poorer for men than women. Privately and publicly insured patients were more likely to be readmitted [odds ratio (OR) 1.6 (95% CI 1.0-2.6) and OR 2.0 (95% CI 1.3–3.2)] and had a shorter stay than the uninsured [4.9 days (95% CI 4.8–5.0) and 5.2 days (95% CI 5.1–5.3) vs. 5.7 days (95% CI 5.4–6.0)], while privately insured patients had considerably lower total charges than those who were uninsured [$34,163 (95% CI 33,214–35,139) vs. $36,335 (95% CI 34,334–38,452)]. As evidenced from this study, there are racial, gender, and insurance disparities in health outcomes. These results and further exploration of these disparities could provide information necessary for strategies to improve these outcomes in at-risk patients diagnosed with osteoporotic fractures.
- 6 October 2016
- Published by Springer Nature in Rheumatology International
- Vol. 36 (12) , 1633-1640
Factors associated with the accuracy of self-reported osteoporosis in the community
We examined the agreement between self-reported osteoporosis and bone mineral density (BMD) results through dual-energy x-ray absorptiometry (DXA) using data from a national representative sample taken from the US communities. Six-year data from the continuous National Health and Nutrition Examination Survey 2005-2006, 2007-2008, and 2009-2010 were merged. Participants included adults 50 years of age or older whose data appeared in both questionnaire and medical examination data files. Self-reported osteoporosis was defined by an affirmative response to a question in the osteoporosis questionnaire then compared with BMD-defined osteoporosis, defined by BMD values taken from the examination data. Agreement between self-reported osteoporosis and DXA results were low. Kappa was only 0.24 (95 % confidence interval = 0.21-0.27), and sensitivity and positive predictive value were 28.0 and 40.8 %, respectively. When stratified by gender or age group, agreement remained poor. Self-report of osteoporosis would not be suitable for accurate prevalence estimates for osteoporosis regardless of gender or age group.
- 6 October 2016
- Published by Springer Nature in Rheumatology International
- Vol. 36 (12) , 1633-1640
Factors associated with the accuracy of self-reported osteoporosis in the community
We examined the agreement between self-reported osteoporosis and bone mineral density (BMD) results through dual-energy x-ray absorptiometry (DXA) using data from a national representative sample taken from the US communities. Six-year data from the continuous National Health and Nutrition Examination Survey 2005-2006, 2007-2008, and 2009-2010 were merged. Participants included adults 50 years of age or older whose data appeared in both questionnaire and medical examination data files. Self-reported osteoporosis was defined by an affirmative response to a question in the osteoporosis questionnaire then compared with BMD-defined osteoporosis, defined by BMD values taken from the examination data. Agreement between self-reported osteoporosis and DXA results were low. Kappa was only 0.24 (95 % confidence interval = 0.21-0.27), and sensitivity and positive predictive value were 28.0 and 40.8 %, respectively. When stratified by gender or age group, agreement remained poor. Self-report of osteoporosis would not be suitable for accurate prevalence estimates for osteoporosis regardless of gender or age group.
- 1 June 2016
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 32 (6) , 547-560
Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women
Objective: The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, anti-microbial activity of the cervicovaginal (CV) fluid lavage (CVL), vaginal flora and p24 antigen production from CV tissues after ex vivo HIV infection between the follicular (FOL) and luteal (LUT) phases of the menstrual cycle. Methods: CV tissue biopsies, CV secretions and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Results: Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 (HSV2) and Escherichia coli (E. coli) by the CVL, vaginal pH or Nugent score or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. Conclusion: The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials. Key Words: Follicular, Luteal, Menstrual Cycle, HIV acquisition, mucosa
- 1 June 2016
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 32 (6) , 547-560
Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women
Objective: The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, anti-microbial activity of the cervicovaginal (CV) fluid lavage (CVL), vaginal flora and p24 antigen production from CV tissues after ex vivo HIV infection between the follicular (FOL) and luteal (LUT) phases of the menstrual cycle. Methods: CV tissue biopsies, CV secretions and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Results: Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 (HSV2) and Escherichia coli (E. coli) by the CVL, vaginal pH or Nugent score or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. Conclusion: The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials. Key Words: Follicular, Luteal, Menstrual Cycle, HIV acquisition, mucosa
- 10 May 2016
- Published by Springer Nature in Osteoporosis International
- Vol. 27 (10) , 2979-2988
The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States
- 10 May 2016
- Published by Springer Nature in Osteoporosis International
- Vol. 27 (10) , 2979-2988
The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States
- 11 June 2015
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 63 (7) , 1401-1406
Is Self‐Reported Sleep Duration Associated with Osteoporosis? Data from a 4‐Year Aggregated Analysis from the National Health and Nutrition Examination Survey
Objectives: To examine the association between self‐reported sleep duration and osteoporosis in a national sample of the U . S . elderly population. Design: Population‐based cross‐sectional study. Setting: Four‐year N ational H ealth and N utrition E xamination S urvey data from two survey cycles between 2005–06 and 2007–08. Participants: Men and women aged 50 and older with data in the surveys and medical examination data files (N = 5,288). Measurements: Osteoporosis diagnosis was based on bone mineral density measurement and self‐report. Sleep duration was ascertained from the sleep survey. Simple and multiple logistic regression models were used to evaluate the association between these two factors. Results: Shorter sleep duration (65). Conclusion: These results underscore the possible linkage between sleep and osteoporosis and the need for additional research on this topic.
- 11 June 2015
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 63 (7) , 1401-1406
Is Self‐Reported Sleep Duration Associated with Osteoporosis? Data from a 4‐Year Aggregated Analysis from the National Health and Nutrition Examination Survey
Objectives: To examine the association between self‐reported sleep duration and osteoporosis in a national sample of the U . S . elderly population. Design: Population‐based cross‐sectional study. Setting: Four‐year N ational H ealth and N utrition E xamination S urvey data from two survey cycles between 2005–06 and 2007–08. Participants: Men and women aged 50 and older with data in the surveys and medical examination data files (N = 5,288). Measurements: Osteoporosis diagnosis was based on bone mineral density measurement and self‐report. Sleep duration was ascertained from the sleep survey. Simple and multiple logistic regression models were used to evaluate the association between these two factors. Results: Shorter sleep duration (65). Conclusion: These results underscore the possible linkage between sleep and osteoporosis and the need for additional research on this topic.
- 5 June 2014
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (9) , 2199-2208
Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data
We studied factors to determine the receipt of osteoporosis treatment in individuals with osteoporosis. Treatment was associated with age, gender, race, body mass index (BMI), family history, arthritis and thyroid problems, daily glucocorticoid use, number of prescriptions and healthcare visits, and insurance type. Osteoporosis is underrecognized and undertreated. Few studies have examined factors associated with osteoporosis treatment in a large, national sample of men and women. We aggregated National Health and Nutrition Examination Survey (NHANES) data from 2005 to 2010 and created a subsample which included individuals 50 years or older who were identified to have osteoporosis either by self-report data or by bone density measurements. The primary outcome was the receipt of osteoporosis treatment either from self-report or from prescription records. Covariates included sociodemographics, clinical characteristics, and access to healthcare variables. Logistic regression analyses were performed to determine factors that associate with osteoporosis treatment. From a sample of 31,0134 participants, 1,133 subjects (3.65 %) met the study criteria. Treatment was associated with age (odds ratio (OR) = 1.14), gender (OR = 13.25), race (OR = 2.23, White vs. Black; OR = 1.76, other vs. Black), BMI (OR = 1.67, normal vs. obese; OR = 2.68, overweight vs. obese), family history of osteoporosis (OR = 1.94), arthritis (OR = 1.43), daily glucocorticoid use (OR = 1.43), number of prescriptions (OR = 1.01), and number of healthcare visits in the past year (OR = 1.44, 4–9 vs. 0–3 visits). All odds ratios were statistically significant. A large number of individuals diagnosed with osteoporosis above the age of 50 remain untreated. It is important for healthcare providers to better assess older adults with osteoporosis, including individuals who frequently receive medical care.
- 5 June 2014
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (9) , 2199-2208
Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data
We studied factors to determine the receipt of osteoporosis treatment in individuals with osteoporosis. Treatment was associated with age, gender, race, body mass index (BMI), family history, arthritis and thyroid problems, daily glucocorticoid use, number of prescriptions and healthcare visits, and insurance type. Osteoporosis is underrecognized and undertreated. Few studies have examined factors associated with osteoporosis treatment in a large, national sample of men and women. We aggregated National Health and Nutrition Examination Survey (NHANES) data from 2005 to 2010 and created a subsample which included individuals 50 years or older who were identified to have osteoporosis either by self-report data or by bone density measurements. The primary outcome was the receipt of osteoporosis treatment either from self-report or from prescription records. Covariates included sociodemographics, clinical characteristics, and access to healthcare variables. Logistic regression analyses were performed to determine factors that associate with osteoporosis treatment. From a sample of 31,0134 participants, 1,133 subjects (3.65 %) met the study criteria. Treatment was associated with age (odds ratio (OR) = 1.14), gender (OR = 13.25), race (OR = 2.23, White vs. Black; OR = 1.76, other vs. Black), BMI (OR = 1.67, normal vs. obese; OR = 2.68, overweight vs. obese), family history of osteoporosis (OR = 1.94), arthritis (OR = 1.43), daily glucocorticoid use (OR = 1.43), number of prescriptions (OR = 1.01), and number of healthcare visits in the past year (OR = 1.44, 4–9 vs. 0–3 visits). All odds ratios were statistically significant. A large number of individuals diagnosed with osteoporosis above the age of 50 remain untreated. It is important for healthcare providers to better assess older adults with osteoporosis, including individuals who frequently receive medical care.
- Open Access
- 5 April 2013
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 49
Prospective assessment of the gastroesophageal microbiome in VLBW neonates
The distal GI microbiota of hospitalized preterm neonates has been established to be unique from that of healthy full-term infants; the proximal GI, more specifically gastroesophageal colonization has not been systematically addressed. We prospectively evaluated early colonization of gastroesophageal portion of the GI tract of VLBW infants.
- 5 April 2013
- Published by Springer Nature in BMC Pediatrics
- Vol. 13 (1) , 49
Open AccessProspective assessment of the gastroesophageal microbiome in VLBW neonates
The distal GI microbiota of hospitalized preterm neonates has been established to be unique from that of healthy full-term infants; the proximal GI, more specifically gastroesophageal colonization has not been systematically addressed. We prospectively evaluated early colonization of gastroesophageal portion of the GI tract of VLBW infants.
- 14 October 2012
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 25 (2) , 505-519
Design effects for sample size computation in three-level designs
Experiments with multiple nested levels where randomization can take place at any level bring challenges to the computation of sample sizes. Formulas derived under simple single-level experiments must be adjusted using multiplicative factors or design effects. In this work, we take a unified approach to finding the design effects in terms of intracluster correlations and present formulas to compute sample sizes of different levels. Equal cluster sample sizes and homogeneous within cluster variances are assumed.
- 14 October 2012
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 25 (2) , 505-519
Design effects for sample size computation in three-level designs
Experiments with multiple nested levels where randomization can take place at any level bring challenges to the computation of sample sizes. Formulas derived under simple single-level experiments must be adjusted using multiplicative factors or design effects. In this work, we take a unified approach to finding the design effects in terms of intracluster correlations and present formulas to compute sample sizes of different levels. Equal cluster sample sizes and homogeneous within cluster variances are assumed.